FDA Recall Terminated

Cochlear Nucleus CI512 Cochlear Implant, REF Z209051, New with Nucleus 5, Sterile EO, Made in Australia, Cochlear Ltd 14 Mars Road, Lane Cove 2066, Australia. The cochlear implant is intended to restore a level of auditory sensation via the electrical stimulation of the auditory nerve.

Recall: Z-0003-2012 · Initiated September 16, 2011

Recall

Recall Number
Z-0003-2012
Event Number
59979
Firm
Cochlear Americas Inc.
FEI Number
3005900820
Product Code
MCM
Status
Terminated
Root Cause
Component design/selection
Initiated
September 16, 2011
Posted
October 3, 2011
Terminated
July 10, 2012
Address
13059 E Peakview Ave, Englewood, CO, 80111-6511

Description

Cochlear Nucleus CI512 Cochlear Implant, REF Z209051, New with Nucleus 5, Sterile EO, Made in Australia, Cochlear Ltd 14 Mars Road, Lane Cove 2066, Australia. The cochlear implant is intended to restore a level of auditory sensation via the electrical stimulation of the auditory nerve.

Reason

Cochlear implant may shut down and cease to function.

Action

Cochlear Americas, Inc. sent an "URGENT MEDICAL DEVICE RECALL" letter dated September 16, 2011 to all affected customers. The letter describes the product, problem, and actions to be taken by the customers. The letter instructs customers to examine their inventory and quarantine the affected product. A recall response form was attached to the letter for customers to complete and return. Contact Cochlear Clinic Customer Service at 877-883-3101 for questions concerning this notice.

Distribution

Worldwide Distribution-USA (nationwide) and countries in Europe and Australia.

Quantity

33,645 units (global); 25,516 (implanted); 1,741 remaining in U.S. Market for implantation.